Vital Options International and The Group Room presents Advocacy in Action: Advocating for Research Advocacy. We bring together the influential leaders of the cancer advocacy community to address the...

Dr. William Bensinger, myeloma expert from the Seattle Cancer Care Alliance, discusses research results that offer hope for patients who experience disease relapse after an allogeneic stem cell transp...

The outlook for patients with follicular lymphoma is becoming increasingly bright. Some long-term studies show that many patients may not require treatment for a very long time. And even when the &quo...

Heinz-Josef Lenz, M.D., FACP, is the Associate Director for Clinical Research and Co-Leader of the Gastrointestinal Cancers Program at the USC Norris Comprehensive Cancer Center. He sat with The Grou...

Dr. Juvenal de Oliveira Filho resume os principais avanços apresentados no encontro deste ano e comenta o impacto das novas pesquisas na prática clínica dos oncologistas brasileiros.

Mark G. Kris, MD from Memorial Sloan-Kettering Cancer Center

Go to http://www.imedex.com... to see the entire DocTalk and to receive CME credit

Overview

Chaired by Dr John Marshall, this overview of the current state of therapy for colorectal cancer includes...

Musa Mayer, a research advocate and founder of the website, AdvancedBC,org, talks about her journey as an advocate for metastatic breast cancer.

Vikram Mathews APL BTG 2011

Dr. Terrence Cescon, Hematologic Oncologist at Berks Hematology/Oncology Associates in Reading, PA discusses the issues related to drug resistance in patients taking TKI's as treatment for CML.